Abbott Laboratories · Operating Cash Flow (Statement)

Latest reported$9.91Bperiod endingJun 30, 2026

ABT Cash from Operations ($959.90M → $9.91B)

Annual operating cash flow (statement)

High-resolution chart · PNG

ABT operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	9,566,000,000
Dec 31, 2024	8,558,000,000
Dec 31, 2023	7,261,000,000
Dec 31, 2022	9,581,000,000
Dec 31, 2021	10,533,000,000
Dec 31, 2020	7,901,000,000
Dec 31, 2019	6,136,000,000
Dec 31, 2018	6,300,000,000
Dec 31, 2017	5,570,000,000
Dec 31, 2016	3,203,000,000
Dec 31, 2015	2,966,000,000
Dec 31, 2014	3,675,000,000
Dec 31, 2013	3,324,000,000
Dec 31, 2012	9,314,401,000
Dec 31, 2011	8,970,077,000
Dec 31, 2010	8,735,981,000
Dec 31, 2009	7,275,160,000
Dec 31, 2008	7,344,191,000
Dec 31, 2007	5,183,843,000
Dec 31, 2006	5,329,241,000
Dec 31, 2005	5,174,416,000
Dec 31, 2004	4,407,943,000
Dec 31, 2003	3,746,448,000
Dec 31, 2002	4,182,944,000
Dec 31, 2001	3,566,848,000
Dec 31, 2000	3,099,618,000
Dec 31, 1999	2,937,521,000
Dec 31, 1998	2,732,901,000
Dec 31, 1997	2,628,767,000
Dec 31, 1996	2,382,062,000
Dec 31, 1995	1,965,581,000
Dec 31, 1994	2,212,137,000
Dec 31, 1993	1,846,909,000
Dec 31, 1992	1,388,800,000
Dec 31, 1991	1,453,200,000
Dec 31, 1990	1,200,900,000
Dec 31, 1989	959,900,000